1. Mohseni Kouchesfehani H, Kiani S, Rostami AA, Fakheri R. Cytotoxic effect of iron oxide nanoparticles on mouse embryonic stem cells by MTT assay. Iran J Toxicol 2013;7(21):849-53.
2. Na HB, Palui G, Rosenberg JT, Ji X, Grant SC, Mattoussi H. Multidentate catechol-based polyethylene glycol oligomers provide enhanced stability and biocompatibility to iron oxide nanoparticles. ACS Nano 2011;6(1):389-99. [
DOI:10.1021/nn203735b]
3. Medarova Z, Pham W, Kim Y, Dai G, Moore A. In vivo imaging of tumor response to therapy using a dual modality imaging strategy. Int J Cancer 2006;118(11):2796-802. [
DOI:10.1002/ijc.21672]
4. Limbach LK, Li Y, Grass RN, Brunner TJ, Hintermann MA, Muller M, et al. Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. Environ Sci Technol 2005;39(23):9370-6. [
DOI:10.1021/es051043o]
5. Mahmoudi M, Simchi A, Vali H, Imani M, Shokrgozar MA, Azadmanesh K, et al. Cytotoxicity and cell cycle effects of bare and poly (vinyl alcohol) coated iron oxide nanoparticles in mouse fibroblasts. Adv Eng Mater 2009;11(12):B243-B50. [
DOI:10.1002/adem.200990035]
6. Verma A, Stellacci F. Effect of surface properties on nanoparticle–cell interactions. Small 2010;6(1):12-21. [
DOI:10.1002/smll.200901158]
7. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005;26(18):3995-4021. [
DOI:10.1016/j.biomaterials.2004.10.012]
8. Dwivedi S, Siddiqui MA, Farshori NN, Ahamed M, Musarrat J, Al-Khedhairy AA. Synthesis, characterization and toxicological evaluation of iron oxide nanoparticles in human lung alveolar epithelial cells. Colloids Surf B 2014;122:209-15. [
DOI:10.1016/j.colsurfb.2014.06.064]
9. Yuqing Ge, Zhang Y, He S, Nie F, Teng G, Gu N. Fluorescence modified chitosan-coated magnetic nanoparticles for high-efficient cellular imaging. Nanoscale Res Lett 2009;4(4):287-8. [
DOI:10.1007/s11671-008-9239-9]
10. Perez JM, Asati A, Nath S, Kaittanis C. Synthesis of Biocompatible Dextran Coated Nanoceria with pH Dependent Antioxidant Properties. Small 2008;4(5):552-6. [
DOI:10.1002/smll.200700824]
11. Nath S, Kaittanis C, Tinkham A, Perez JM. Dextran-coated gold nanoparticles for the assessment of antimicrobial susceptibility. Anal Chem 2008;80(4):1033-8. [
DOI:10.1021/ac701969u]
12. Khoei S, Mahdavi SR, Fakhimikabir H, Shakeri-Zadeh A, Hashemian A. The role of iron oxide nanoparticles in the radiosensitization of human prostate carcinoma cell line DU145 at megavoltage radiation energies. Int J Radiat Biol 2014;90(5):351-6. [
DOI:10.3109/09553002.2014.888104]
13. Jeng HA, Swanson J. Toxicity of metal oxide nanoparticles in mammalian cells. J Environ Sci Health Part A 2006;41(12):2699-711. [
DOI:10.1080/10934520600966177]
14. Kim JS, Yoon T-J, Yu KN, Kim BG, Park SJ, Kim HW, et al. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci 2006;89(1):338-47. [
DOI:10.1093/toxsci/kfj027]
15. Karlsson HL, Gustafsson J, Cronholm P, Möller L. Size-dependent toxicity of metal oxide particles-a comparison between nano-and micrometer size. Toxicol Lett 2009;188(2):112-8. [
DOI:10.1016/j.toxlet.2009.03.014]
16. Karlsson HL, Cronholm P, Gustafsson J, Moller L. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol 2008;21(9):1726-32. [
DOI:10.1021/tx800064j]
17. Villanueva A, Canete M, Roca AG, Calero M, Veintemillas-Verdaguer S, Serna CJ, et al. The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells. Nanotechnology 2009;20(11):115103-4. [
DOI:10.1088/0957-4484/20/11/115103]
18. Ankamwar B, Lai T, Huang J, Liu R, Hsiao M, Chen CH, et al. Biocompatibility of Fe3O4 nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells. Nanotechnology 2010;21(7):075102-3. [
DOI:10.1088/0957-4484/21/7/075102]
19. Hoskins C, Cuschieri A, Wang L. The cytotoxicity of polycationic iron oxide nanoparticles: common endpoint assays and alternative approaches for improved understanding of cellular response mechanism. J Nanobiotechnol 2012;10(1):1-2. [
DOI:10.1186/1477-3155-10-15]
20. Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Labhasetwar V. Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol Pharmaceutics 2008;5(2):316-27. [
DOI:10.1021/mp7001285]
21. Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Delivery Rev 2009;61(6):428-37. [
DOI:10.1016/j.addr.2009.03.009]
22. Barbaro D, Di Bari L, Gandin V, Evangelisti C, Vitulli G, Schiavi E, et al. Glucose-coated superparamagnetic iron oxide nanoparticles prepared by metal vapour synthesis are electively internalized in a pancreatic adenocarcinoma cell line expressing GLUT1 transporter. Plos One 2015;10(4):59-60. [
DOI:10.1371/journal.pone.0123159]
23. Liu G, Gao J, Ai H, Chen X. Applications and potential toxicity of magnetic iron oxide nanoparticles. Small 2013;9(10):1533-45. [
DOI:10.1002/smll.201201531]
24. Sanganeria P, Sachar S, Chandra S, Bahadur D, Ray P, Khanna A. Cellular internalization and detailed toxicity analysis of protein immobilized iron oxide nanoparticles. J Biomed Mater Res Part B 2015;103(1):125-34. [
DOI:10.1002/jbm.b.33178]